首页 | 本学科首页   官方微博 | 高级检索  
     

食管癌VMAT与IMRT剂量比较的Meta分析
引用本文:高瀚,贾鹏飞,陈炳森,汤乐民. 食管癌VMAT与IMRT剂量比较的Meta分析[J]. 中华放射肿瘤学杂志, 2017, 26(9): 1055-1061. DOI: 10.3760/cma.j.issn.1004-4221.2017.09.015
作者姓名:高瀚  贾鹏飞  陈炳森  汤乐民
作者单位:226001 南通大学医学院(高瀚、陈炳森、汤乐民);南通大学附属医院肿瘤放疗科(贾鹏飞)
摘    要:目的 对食管癌VMAT与IMRT靶区和OAR剂量比较行Meta分析。方法 文献检索纳入相关研究,分析靶区和OAR剂量参数、机器跳数及治疗时间。结果 17项研究的323病例纳入Meta分析。VMAT计划中GTV的Dmean、在总剂量≤50.4 Gy时PTV的Dmean和在总剂量>50.4 Gy时PTV的Dmax优于IMRT (P=0.009、0.043、0.039)。心脏Dmean、V30、V40,脊髓Dmax,肺V5、V10、Dmean差异均无统计学意义(P>0.05);VMAT计划中肺的V15、V20、V30优于IMRT计划(P=0.001、0.000、0.023)。VMAT计划中单次照射1.8、2.0 Gy的机器跳数较IMRT计划分别减少275.4、134.2 MU (P=0.000、0.022);VMAT计划中单次照射1.8、2.0 Gy的TT比IMRT计划分别缩短323.5、193.7 s (P=0.000、0.009)。结论 VMAT计划能显著减少TT和机器跳数、提高设备使用率,降低肺受照剂量和RP发生风险。VMAT与IMRT相比在照射总剂量≤50.4 Gy时除PTV的Dmean和GTV的Dmean、Dmax外,靶区其他剂量参数均无明显优势。对脊髓和心脏保护VMAT也无明显优势。

关 键 词:食管肿瘤/容积调强弧形疗法  食管肿瘤/调强放射疗法  荟萃分析  
收稿时间:2016-07-18

Dosimetric comparison between volumetric-modulated arc therapy and intensity-modulated radiotherapy for esophageal cancer:a meta-analysis
Gao Han,Jia Pengfei,Chen Bingsen,Tang Lemin. Dosimetric comparison between volumetric-modulated arc therapy and intensity-modulated radiotherapy for esophageal cancer:a meta-analysis[J]. Chinese Journal of Radiation Oncology, 2017, 26(9): 1055-1061. DOI: 10.3760/cma.j.issn.1004-4221.2017.09.015
Authors:Gao Han  Jia Pengfei  Chen Bingsen  Tang Lemin
Affiliation:Medical College of Nantong University (Gao H,Chen BS,Tang LM);Department of Radiation Oncology,Cancer Hospital,Affiliated to Nantong University (Jia PF),Nantong 226001,China
Abstract:Objective To investigate the dosimetric comparison of target volumes and organs at risk (OAR) between volumetric-modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) for esophageal cancer by a meta-analysis.Methods A literature search was performed to collect the clinical studies on dosimetric comparison between VMAT and IMRT.The primary endpoints of interest were dosimetric parameters of target volumes and OAR, number of monitor units (MUs), and treatment time (TT).Results A total of 17 studies involving 323 patients were included in this meta-analysis.When the total dose was>50.4 Gy, VMAT showed significantly lower mean dose (Dmean) of gross tumor volume (GTV) and maximum dose (Dmax) of planning target volume (PTV) than IMRT (P=0.009;P=0.039).There were no significant differences in Dmean, V30, and V40 of the heart, Dmax of the spinal cord, and V5, V10, and Dmean of the lung between VMAT and IMRT (P>0.05).VMAT showed significantly lower V15, V20, and V30 of the lung than IMRT (P=0.001;P=0.000;P=0.023).When the single dose was 1.8 Gy and 2.0 Gy, VMAT showed significantly lower TT (reduced by 323.5 s and 193.7 s) and number of MUs (reduced by 275.4 MU and 134.2 MU) than IMRT (P=0.000 and 0.009;P=0.000 and 0.022).Conclusions VMAT can significantly reduce TT, MUs, irradiation dose to the lung, and the risk of radiation pneumonitis, and improve the utilization rate of equipment.Compared with IMRT, VMAT has no significant advantages in protection of the spinal cord and the heart and dosimetric parameters of target volumes except Dmean of PTV and Dmean and Dmax of GTV when the total dose was ≤50.4 Gy.
Keywords:Esophageal neoplasms/volumetric-modulated arc therapy  Esophageal neoplasms/intensity-modulated radiotherapy  Meta-analysis
本文献已被 万方数据 等数据库收录!
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号